Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 2700 of 3284 entries
View as:

A Two-week Study Assessing the Onset of Effect Questionnaire (OEQ) Administered Daily Versus Weekly in Adult Subjects

Phase: N/A Priority: Normal
NCT ID: NCT00449527 Org: User:
Start: 03/31/07 End: 08/31/07 Due: 08/31/08

Savolitinib Plus Osimertinib Versus Platinum-based Doublet Chemotherapy in Participants With Non-Small Cell Lung Cancer Who Have Progressed on Osimertinib Treatment

Phase: N/A Priority: Normal
NCT ID: NCT05261399 Org: User:
Start: 08/03/22 End: 12/17/26 Due: 12/17/27

ARTEMIS DIANE T790M (An Amino Acid Substitution at Position 790 in EGFR, From a Threonine (T) to a Methionine (M)) Mutation at Hospital Laboratories in Comparison With Central Laboratory

Phase: N/A Priority: Normal
NCT ID: NCT02991274 Org: User:
Start: 01/16/17 End: 06/29/18 Due: 06/29/19

Phase II Iressa Versus Vinorelbine (INVITE)

Phase: N/A Priority: Normal
NCT ID: NCT00256711 Org: User:
Start: 07/31/04 End: 02/28/06 Due: 02/28/07

Responsiveness of Lower Airways in Adult Patients (18-60 Years) With Stable Asthma After Treatment With Ciclesonide and Fluticasone Propionate (BY9010/NL-101)

Phase: N/A Priority: Normal
NCT ID: NCT00306163 Org: User:
Start: 05/31/06 End: 09/30/08 Due: 09/30/09

Continuing Sodium Zirconium Cyclosilicate (SZC) After Discharge Study

Phase: N/A Priority: Normal
NCT ID: NCT05347693 Org: User:
Start: 03/24/22 End: 12/10/24 Due: 12/10/25

Efficacy and Safety Study of Olaparib in Combination With Paclitaxel to Treat Advanced Gastric Cancer.

Phase: N/A Priority: Normal
NCT ID: NCT01924533 Org: User:
Start: 09/03/13 End: 03/27/23 Due: 03/27/24

Fulvestrant (FASLODEX™) as a Treatment in Postmenopausal Women With Estrogen Receptor Positive Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00093002 Org: User:
Start: 06/30/04 End: 07/31/07 Due: 07/31/08

A Study of CIN-107 in Adults With Primary Aldosteronism

Phase: N/A Priority: Normal
NCT ID: NCT04605549 Org: User:
Start: 03/08/21 End: 10/28/24 Due: 10/28/25

A Phase-II Study Of TOMUDEX Plus Radiotherapy In Subject With Inoperable or Recurrent Rectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00590278 Org: User:
Start: 08/31/02 End: - Due: -

Aclidinium Bromide Post-Authorisation Safety Study to Evaluate the Risk of Cardiovascular Endpoints

Phase: N/A Priority: Normal
NCT ID: NCT03290287 Org: User:
Start: 03/01/17 End: 06/30/22 Due: 06/30/23

Study of Incidence of Drug-induced Upper Gastrointestinal Bleeding

Phase: N/A Priority: Normal
NCT ID: NCT01155401 Org: User:
Start: 06/30/10 End: 06/30/11 Due: 06/30/12

Observational to Investigate the Efficacy of CRESTOR 5mg in Reaching LDL-C Target Goals in Patients Who Are at High Risk for a Cardiovascular Event

Phase: N/A Priority: Normal
NCT ID: NCT00347217 Org: User:
Start: 02/28/06 End: 01/31/09 Due: 01/31/10

Study to Evaluate Tezepelumab on Airway Inflammation in Adults With Uncontrolled Asthma (CASCADE)

Phase: N/A Priority: Normal
NCT ID: NCT03688074 Org: User:
Start: 11/02/18 End: 11/16/20 Due: 11/16/21

Exenatide Compared With Twice-Daily Biphasic Insulin Aspart in Patients With Type 2 Diabetes Using Sulfonylurea and Metformin

Phase: N/A Priority: Normal
NCT ID: NCT00082407 Org: User:
Start: 11/30/03 End: 07/31/08 Due: 07/31/09

Exacerbations and Their Outcomes International (EXACOS International)

Phase: N/A Priority: Normal
NCT ID: NCT04928417 Org: User:
Start: 11/26/21 End: 11/30/22 Due: 11/30/23

Study of Durvalumab + Tremelimumab, Durvalumab, and Placebo in Limited Stage Small-Cell Lung Cancer in Patients Who Have Not Progressed Following Concurrent Chemoradiation Therapy

Phase: N/A Priority: Normal
NCT ID: NCT03703297 Org: User:
Start: 09/27/18 End: 03/05/26 Due: 03/05/27

A Study to Investigate Safety, Tolerability, and Pharmacokinetics of Oral AZD0233 Compared With Placebo in Healthy Adult Participants.

Phase: N/A Priority: Normal
NCT ID: NCT06381466 Org: User:
Start: 04/01/24 End: 09/16/25 Due: 09/16/26

Effect of Exenatide Plus Metformin vs. Insulin Aspart Plus Metformin on Glycemic Control and Hypoglycemia in Patients With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT00434954 Org: User:
Start: 02/28/07 End: 06/30/09 Due: 06/30/10

Investigation of Potential Additive Inhibitory Effects on HPA-Axis of Ciclesonide Nasal Spray When Administered Concomitantly With Orally Inhaled Beclomethasone Dipropionate (HFA-BDP) in Patients With Perennial Allergic Rhinitis (PAR) (BY9010/M1-408)

Phase: N/A Priority: Normal
NCT ID: NCT00659048 Org: User:
Start: 12/31/04 End: 12/31/05 Due: 12/31/06

A Cross-sectional Study on the Prevalence and Extraesophageal Symptoms of Gastroesophageal Reflux Disease(GERD) in Patients With Upper GI Symptoms, Visiting the Outpatient Departments of Peripheral Hospitals in Greece

Phase: N/A Priority: Normal
NCT ID: NCT01215305 Org: User:
Start: 10/31/10 End: 03/31/11 Due: 03/31/12

Study in Healthy Males to Assess Bioavailability of Single Fostamatinib With iv Micro Tracer Dose

Phase: N/A Priority: Normal
NCT ID: NCT01598571 Org: User:
Start: 05/31/12 End: 08/31/12 Due: 08/31/13

A Bioavailability and Food Effect Study of AZD5462 in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT05512806 Org: User:
Start: 08/24/22 End: 11/07/22 Due: 11/07/23

AZD4573 as Monotherapy or in Combinations With Anti-cancer Agents in Patients With r/r PTCL or r/r cHL

Phase: N/A Priority: Normal
NCT ID: NCT05140382 Org: User:
Start: 12/15/21 End: 02/16/24 Due: 02/16/25

EVOLVE Study: The Real-life Clinical Practice With Tezepelumab in Greece

Phase: N/A Priority: Normal
NCT ID: NCT06724575 Org: User:
Start: 12/17/24 End: 06/30/28 Due: 06/30/29